InVivo Therapeutics Holdings Corporation

InVivo Therapeutics Holdings Corporation

NVIV
InVivo Therapeutics Holdings CorporationUS flagNASDAQ Capital Market
0.32
USD
-0.17
- -
995,918.00Market Cap

InVivo Therapeutics Holdings Corporation (NVIV) Stock Split History

Learn about InVivo Therapeutics Holdings Corporation's most recent 1-for-25 basis stock split on April 27, 2022. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about InVivo Therapeutics Holdings Corporation's most recent stock split

Split Date: 2022-04-27
Split Ratio: 1:25
Price Before Split: $0.23
Price After Split: $0.01

Developer API

Get NVIV split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/NVIV

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 25.00 times fewer shares (a 1:25 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of InVivo Therapeutics Holdings Corporation's stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2022-04-271:25Yes$0.23$0.01
2020-02-121:30Yes$0.27$0.01
2018-04-171:25Yes$0.38$0.02
2015-04-081:4Yes$3.04$0.76

About InVivo Therapeutics Holdings Corporation

Company overview and industry information

InVivo Therapeutics Holdings Corporation (NVIV) operates in the Biotechnology industry. The recent 1-for-25 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to InVivo Therapeutics Holdings Corporation Summary

Last updated: 7/6/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.